Why Doctors Dismiss Stem Cell Therapy—and What Patients Should Know

Why Many Doctors Dismiss Stem Cell Therapy – and What Patients Need to Know

Video Summary

Dr. Yi Song explains why many patients ask about stem cell therapy but leave confused after their doctors dismiss it as “unproven.” While the FDA classifies stem cell therapy as experimental, research worldwide shows promising results for conditions like autoimmune disease, Parkinson’s, and ALS. Dr. Song highlights how the medical system, shaped to benefit pharmaceutical companies and patents, has little incentive to approve natural treatments like umbilical cord stem cells. Most doctors, trained within this system, won’t recommend it—leaving patients to do their own research, advocate for their health, and seek therapies that target root causes rather than just symptoms.

Conditions We Treat

  • Osteoarthritis

  • Rheumatoid Arthritis

  • Psoriatic Arthritis

  • Neuropathy

  • Chronic Pain

  • Long COVID

  • Multiple Sclerosis

  • COPD

  • Autoimmune Conditions

These are just a few of the conditions we address with regenerative therapy.

See the Full List of Conditions We Treat

Why Many Doctors Dismiss Stem Cell Therapy—and What Patients Need to Know

Stem cell therapy is one of the most talked-about regenerative treatments in the world today. Patients with autoimmune conditions, Parkinson’s, ALS, and lupus are hearing about life-changing results abroad—but when they ask their doctors, the answer is almost always the same: “It’s unproven.” This leaves many people confused, stuck between curiosity and caution.

The truth is more complicated than a quick dismissal. As Dr. Yi Song explains, Western-trained doctors often discourage stem cell therapy not because it’s unsafe, but because it doesn’t fit within a pharmaceutical-driven system. Understanding why can empower patients to make more informed choices about their health.

Why Doctors Say Stem Cell Therapy Is “Unproven”

When patients bring up stem cell therapy with their neurologists or rheumatologists, the response is nearly always skeptical. Doctors point out that umbilical cord stem cell therapy is not FDA-approved and is therefore considered experimental. From their perspective, this means it doesn’t meet the standards of traditional clinical medicine.
However, this label of “unproven” does not necessarily mean “unsafe” or “ineffective.” All over the world, clinics and researchers are studying regenerative medicine to help patients who haven’t found relief in conventional care. The challenge is that these international results don’t automatically translate into FDA approval in the United States.

The Influence of the Pharmaceutical System

To understand the resistance, it helps to look at the history of Western medicine. As Dr. Song points out, over 95% of practicing doctors in the U.S. were trained in a system designed more than a century ago, shaped heavily by pharmaceutical interests.

The FDA approval process is closely tied to patents, profits, and marketability. A natural treatment such as umbilical cord stem cells cannot be patented in the same way a synthetic drug can. That means there’s little financial incentive for pharmaceutical companies—or even regulatory agencies—to push stem cell therapies through the approval pipeline.

This creates a system where treatments that could reduce dependency on medications or replace expensive surgical procedures, like joint replacements, are viewed as threats rather than opportunities.

Why Many Doctors Don’t Recommend It

Doctors practice within the framework they were trained in, and for most, that framework leaves little room for regenerative medicine. Their education and daily practice reinforce a model of treating disease with drugs and procedures, rather than addressing root causes.

Unless a physician chooses to “step outside the box,” they may never truly explore or recommend stem cell therapy. This doesn’t necessarily mean your doctor is against you—it means their system of training and practice has closed off other options.

Becoming Your Own Advocate

For patients navigating chronic or autoimmune conditions, waiting on traditional approval may mean years—if not decades—without solutions. That’s why Dr. Song emphasizes the importance of becoming your own advocate.

Doing your own research, asking questions, and exploring multiple perspectives are essential steps. Relying solely on conventional advice can keep you trapped in a cycle of symptom management rather than true healing.

While doctors may guide you in some aspects of care, only you can make the decision to explore whether regenerative treatments might offer the long-term vitality you’re seeking.

Moving Beyond Symptom Management

Traditional Western medicine is highly effective at treating emergencies and managing acute conditions. But when it comes to aging and chronic illness, it often focuses only on symptoms. Medications can suppress pain, inflammation, or neurological decline—but they rarely address the underlying cause.

Stem cell therapy offers a fundamentally different approach: working with the body’s own healing potential. For patients tired of endless prescriptions and temporary fixes, this shift can feel like a path back to real health rather than an endless cycle of management.

Final Thoughts from Dr. Song

Stem cell therapy challenges the very foundation of the pharmaceutical-driven medical system. That’s why so many doctors quickly dismiss it. But dismissals don’t change the reality that thousands of patients are finding hope through regenerative treatments around the world.

You don’t need to accept being told “it’s unproven” as the final word. By doing your own research and becoming an active advocate for your health, you can make choices that align with your long-term goals for vitality, healing, and quality of life.

Ready to Talk About Your Treatment Options?

Start with a personalized consultation to explore the right stem cell therapy for you.